Definitive Radiation for High-Risk Spine Metastases

NCT ID: NCT06165419

Last Updated: 2025-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-14

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Cancer Metastatic Lung Cancer Metastatic Breast Cancer Metastatic Tumor Metastatic Tumor of Bone Metastatic Tumor to the Spine Spine Metastases Metastasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SBRT to the spine

Group Type EXPERIMENTAL

SBRT to the spine

Intervention Type RADIATION

Stereotactic body radiation therapy (SBRT) administered to spine metastases

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SBRT to the spine

Stereotactic body radiation therapy (SBRT) administered to spine metastases

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease
* Metastatic spine involvement documented by imaging
* Involvement of maximum 3 contiguous vertebral bodies at the index site
* Intact neurologic function, or only minor neurologic deficits with muscle strength greater or equal to 4 out of 5 with or without steroids
* An evaluation by an radiation oncology and orthopedic spine/neurosurgery attending
* ECOG Performance Status of 0-3

Patients are ineligible if they have:

* An unstable spine defined as a Spinal Instability Neoplastic Score (SINS) greater than 12
* Had previous surgery or radiation to address the target spinal metastases
* Radiosensitive tumors (e.g. small cell lung cancer, lymphoma, multiple myeloma, and germ-cell tumors)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Texas Health Science Center at San Antonio

OTHER

Sponsor Role collaborator

Stony Brook University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kartik Mani

Assistant Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kartik Mani, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Stony Brook Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stony Brook University Hospital

Stony Brook, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hermina Munoz, RN

Role: CONTACT

631-216-2990

Lucia Joya

Role: CONTACT

631-216-2998

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caterina Vacchi-Suzzi, PhD

Role: primary

631-216-2993

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB2023-00421

Identifier Type: OTHER

Identifier Source: secondary_id

SBU-RT-MESCC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spinal met_radiosurgery/SBRT Study
NCT01231061 COMPLETED PHASE2
Proton SBRT for Spinal Metastasis
NCT06895564 RECRUITING NA